{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:54:32Z","timestamp":1781150072477,"version":"3.54.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["22\\u20130348"],"award-info":[{"award-number":["22\\u20130348"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 27271"],"award-info":[{"award-number":["IG 27271"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["25364"],"award-info":[{"award-number":["25364"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["31563"],"award-info":[{"award-number":["31563"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CN00000041"],"award-info":[{"award-number":["CN00000041"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CUP C93C22002780006"],"award-info":[{"award-number":["CUP C93C22002780006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["TRANSION"],"award-info":[{"award-number":["TRANSION"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.phrs.2026.108150","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:49:36Z","timestamp":1771573776000},"page":"108150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin\/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models"],"prefix":"10.1016","volume":"225","author":[{"given":"Sofia","family":"Parrasia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8028-5397","authenticated-orcid":false,"given":"Carlotta","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Varanita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-7478","authenticated-orcid":false,"given":"Valentina","family":"Brillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.L.","family":"Abdel-Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ongaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Honisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Angi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-4141","authenticated-orcid":false,"given":"Magdalena","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3369-1920","authenticated-orcid":false,"given":"Filippo","family":"Bergamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Bossio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Gulbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Carrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Zoratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-0749","authenticated-orcid":false,"given":"Andrea","family":"Mattarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-6176","authenticated-orcid":false,"given":"Paolo","family":"Ruzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7638-6865","authenticated-orcid":false,"given":"Lucia","family":"Biasutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-3947","authenticated-orcid":false,"given":"Ildiko","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.phrs.2026.108150_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.4682","article-title":"Incidence of pancreas and colorectal adenocarcinoma in the US","volume":"8","author":"Bussetty","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.phrs.2026.108150_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"issue":"8059","key":"10.1016\/j.phrs.2026.108150_bib4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","article-title":"MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC","volume":"640","author":"Fiorini","year":"2025","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phrs.2026.108150_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41568-023-00628-9","article-title":"How protons pave the way to aggressive cancers","volume":"23","author":"Swietach","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2026.108150_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.37349\/etat.2024.00202","article-title":"Role of STAT3 in pancreatic cancer","volume":"5","author":"Hamel","year":"2024","journal-title":"Explor Target Antitumor Ther."},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0016-5085(03)01064-3","article-title":"Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer","volume":"125","author":"Scholz","year":"2003","journal-title":"Gastroenterology"},{"issue":"36","key":"10.1016\/j.phrs.2026.108150_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn9361","article-title":"BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway","volume":"10","author":"Prosdocimi","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3635","article-title":"The roles of K(+) channels in cancer","volume":"14","author":"Pardo","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1574892811308010053","article-title":"Potassium channels: novel emerging biomarkers and targets for therapy in cancer","volume":"8","author":"Amico","year":"2013","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.phrs.2026.108150_bib12","doi-asserted-by":"crossref","unstructured":"A. Teisseyre, A. Palko-Labuz, K. Sroda-Pomianek, K. Michalak, Voltage-Gated Potassium Channel Kv1.3 as a Target in Therapy of Cancer, 2019.","DOI":"10.3389\/fonc.2019.00933"},{"key":"10.1016\/j.phrs.2026.108150_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00283","article-title":"The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancer","volume":"4","author":"Comes","year":"2013","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108150_bib14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/bjc.2015.28","article-title":"hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma","volume":"112","author":"Lastraioli","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2026.108150_bib15","article-title":"Ion channels orchestrate pancreatic ductal adenocarcinoma progression and therapy","volume":"11","author":"Hofschr\u00f6er","year":"2020","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2026.108150_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/hsz-2022-0232","article-title":"Pancreatic K(Ca)3.1 channels in health and disease","volume":"404","author":"Soret","year":"2023","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12672-025-02001-8","article-title":"Identification of KCNJ5 gene an adverse prognosis associated novel onco-ionchannel in Indian pancreatic cancer cohort","volume":"16","author":"Bararia","year":"2025","journal-title":"Discov. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108150_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","article-title":"Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo","volume":"31","author":"Leanza","year":"2017","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.phrs.2026.108150_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112618","article-title":"Inhibition of a mitochondrial potassium channel in combination with gemcitabine and abraxane drastically reduces pancreatic ductal adenocarcinoma in an immunocompetent orthotopic murine model","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00109-023-02290-y","article-title":"Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo","volume":"101","author":"Patel","year":"2023","journal-title":"J. Mol. Med."},{"issue":"7","key":"10.1016\/j.phrs.2026.108150_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00109-024-02456-2","article-title":"Sphingosine is involved in PAPTP-induced death of pancreas cancer cells by interfering with mitochondrial functions","volume":"102","author":"Patel","year":"2024","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/156652412799218868","article-title":"Genomic sequencing of key genes in mouse pancreatic cancer cells","volume":"12","author":"Wang","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108150_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067330","article-title":"Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer","volume":"8","author":"Courtin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2026.108150_bib24","article-title":"Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma","author":"Zaccagnino","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108150_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101705","article-title":"Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family","volume":"37","author":"Peruzzo","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108150_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107874","article-title":"Mitochondrial K(+) channels and their implications for disease mechanisms","volume":"227","author":"Checchetto","year":"2021","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-022-02249-w","article-title":"Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model","volume":"41","author":"Severin","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib29","first-page":"61","article-title":"Targeting Pancreatic Ductal Adenocarcinoma (PDAC)","volume":"55","author":"Parrasia","year":"2021","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.phrs.2026.108150_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101846","article-title":"Targeting mitochondrial ion channels for cancer therapy","volume":"42","author":"Szabo","year":"2021","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108150_bib31","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/acsptsci.5c00241","article-title":"Advancing cancer-targeted nanotherapies with tumor homing peptides","volume":"8","author":"Rocchi","year":"2025","journal-title":"ACS Pharm. Transl. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051508","article-title":"DA7R: a 7-letter zip code to target PDAC","volume":"15","author":"Parrasia","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib33","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-021-21858-1","article-title":"Tumor-penetrating therapy for \u03b25 integrin-rich pancreas cancer","volume":"12","author":"Hurtado de Mendoza","year":"2021","journal-title":"Nat. Commun."},{"issue":"38","key":"10.1016\/j.phrs.2026.108150_bib34","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","author":"Teesalu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"49","key":"10.1016\/j.phrs.2026.108150_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112457118","article-title":"A widespread viral entry mechanism: the C-end Rule motif-neuropilin receptor interaction","volume":"118","author":"Balistreri","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.phrs.2026.108150_bib36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(22)00167-4","article-title":"Dual \u03b1V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study","volume":"7","author":"Dean","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib37","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI92284","article-title":"Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer","volume":"127","author":"Liu","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"20","key":"10.1016\/j.phrs.2026.108150_bib38","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1021\/acs.jcim.3c01071","article-title":"Molecular view on the iRGD peptide binding mechanism: implications for integrin activity and selectivity profiles","volume":"63","author":"Amore","year":"2023","journal-title":"J. Chem. Inf. Model"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191052","article-title":"Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos","volume":"13","author":"David","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib40","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1096\/fj.201600827R","article-title":"Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier","volume":"31","author":"Molino","year":"2017","journal-title":"Faseb J."},{"issue":"8","key":"10.1016\/j.phrs.2026.108150_bib41","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1161\/ATVBAHA.125.322498","article-title":"Potential roles of SNX17, Rab11, and Rab5 in LDLR recycling","volume":"45","author":"Zhao","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"24","key":"10.1016\/j.phrs.2026.108150_bib42","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.phrs.2026.108150_bib43","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1073\/pnas.1421601112","article-title":"Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma","volume":"112","author":"Guillaumond","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib44","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s42003-021-02508-0","article-title":"LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma","volume":"4","author":"Acier","year":"2021","journal-title":"Commun Biol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108150_bib46","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.7150\/thno.24378","article-title":"Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting","volume":"8","author":"Klingler","year":"2018","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00006676-199203000-00006","article-title":"A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer","volume":"7","author":"Abbruzzese","year":"1992","journal-title":"Pancreas"},{"key":"10.1016\/j.phrs.2026.108150_bib48","unstructured":"K.T. Cheng, (111)In-Tetraazacyclododecane-N,N\u2019,N\u2019\u2019,N\u2019\u2019\u2019-tetraacetic acid-HHEAYGWMDF-NH(2) peptide, Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information (US), Bethesda (MD), 2004."},{"issue":"10","key":"10.1016\/j.phrs.2026.108150_bib49","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s00259-008-0803-4","article-title":"Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours","volume":"35","author":"Good","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7150\/ijbs.14952","article-title":"The role of gastrin and CCK receptors in pancreatic cancer and other malignancies","volume":"12","author":"Smith","year":"2016","journal-title":"Int J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2026.108150_bib51","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/MPA.0000000000000194","article-title":"Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice","volume":"43","author":"Smith","year":"2014","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.phrs.2026.108150_bib52","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/mc.23084","article-title":"Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention","volume":"58","author":"Mohammed","year":"2019","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib53","first-page":"309","article-title":"Quantitative analysis of gastrin mRNA and peptide in normal and cancerous human pancreas","volume":"2","author":"Smith","year":"1998","journal-title":"Int J. Mol. Med"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0016-5085(03)00697-8","article-title":"Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue","volume":"125","author":"Reubi","year":"2003","journal-title":"Gastroenterology"},{"issue":"34","key":"10.1016\/j.phrs.2026.108150_bib55","doi-asserted-by":"crossref","first-page":"24485","DOI":"10.1074\/jbc.R700022200","article-title":"A marriage of convenience: beta-subunits and voltage-dependent K+ channels","volume":"282","author":"Torres","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.phrs.2026.108150_bib56","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1242\/jcs.056689","article-title":"KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating","volume":"122","author":"Sol\u00e9","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.phrs.2026.108150_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ab.2019.03.010","article-title":"Ponceau S waste: Ponceau S staining for total protein normalization","volume":"575","author":"Sander","year":"2019","journal-title":"Anal. Biochem"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020129","article-title":"An Angiopep2-PAPTP construct overcomes the blood-brain barrier. new perspectives against brain tumors","volume":"14","author":"Parrasia","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib59","first-page":"893","article-title":"The cell-specific elastase I enhancer comprises two domains","volume":"8","author":"Kruse","year":"1988","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib60","article-title":"An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice","volume":"4","author":"O'Brien","year":"2023","journal-title":"STAR Protoc."},{"issue":"13","key":"10.1016\/j.phrs.2026.108150_bib61","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1039\/D0CS01096K","article-title":"NBD-based synthetic probes for sensing small molecules and proteins: design, sensing mechanisms and biological applications","volume":"50","author":"Jiang","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/labinvest.2017.127","article-title":"Experimental models of pancreatic cancer desmoplasia","volume":"98","author":"Suklabaidya","year":"2018","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/physrev.00044.2016","article-title":"Ion channels in cancer: are cancer hallmarks oncochannelopathies?","volume":"98","author":"Prevarskaya","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2026.108150_bib65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-biophys-092622-094853","article-title":"Mitochondrial ion channels","volume":"52","author":"Szabo","year":"2023","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.phrs.2026.108150_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.611853","article-title":"Voltage-gated potassium channels as regulators of cell death","volume":"8","author":"Bachmann","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"S1","key":"10.1016\/j.phrs.2026.108150_bib67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.33594\/000000198","article-title":"The contribution of mitochondrial ion channels to cancer development and progression","volume":"53","author":"Bachmann","year":"2019","journal-title":"Cell Physiol. Biochem"},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib68","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/14728222.2016.1112792","article-title":"The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies","volume":"20","author":"Perez-Verdaguer","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1638","key":"10.1016\/j.phrs.2026.108150_bib69","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0106","article-title":"Ion channels and anti-cancer immunity","volume":"369","author":"Panyi","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"7621","key":"10.1016\/j.phrs.2026.108150_bib70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature19364","article-title":"Ionic immune suppression within the tumour microenvironment limits T cell effector function","volume":"537","author":"Eil","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/0008-5472.CAN-16-2372","article-title":"Kv1.3 channels mark functionally competent CD8+ tumor-infiltrating lymphocytes in head and neck cancer","volume":"77","author":"Chimote","year":"2017","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.imlet.2009.04.008","article-title":"Potassium channel expression in human CD4+ regulatory and na\u00efve T cells from healthy subjects and multiple sclerosis patients","volume":"124","author":"Varga","year":"2009","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94015-9","article-title":"KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology","volume":"11","author":"Vallejo-Gracia","year":"2021","journal-title":"Sci. Rep."},{"issue":"47","key":"10.1016\/j.phrs.2026.108150_bib74","doi-asserted-by":"crossref","first-page":"46307","DOI":"10.1074\/jbc.M304388200","article-title":"Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages","volume":"278","author":"Vicente","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.phrs.2026.108150_bib75","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.2174\/092986712803833281","article-title":"Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels","volume":"19","author":"Leanza","year":"2012","journal-title":"Curr. Med Chem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib76","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/acsabm.0c01336","article-title":"Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors","volume":"4","author":"Mamnoon","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"4","key":"10.1016\/j.phrs.2026.108150_bib77","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1039\/C7ME00050B","article-title":"Targeted drug delivery using iRGD peptide for solid cancer treatment","volume":"2","author":"Liu","year":"2017","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.phrs.2026.108150_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.intimp.2019.02.027","article-title":"Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer","volume":"70","author":"Yang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108150_bib79","doi-asserted-by":"crossref","first-page":"116050","DOI":"10.1016\/j.ejmech.2023.116050","article-title":"Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy","volume":"265","author":"Singh","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.phrs.2026.108150_bib80","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","article-title":"Peptides as multifunctional players in cancer therapy","volume":"55","author":"Vadevoo","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108150_bib81","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0024-3205(97)00414-1","article-title":"mRNAs encoding CCKB but not CCKA receptors are expressed in human T lymphocytes and Jurkat lymphoblastoid cells","volume":"61","author":"Cuq","year":"1997","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00262-017-2077-9","article-title":"Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice","volume":"67","author":"Smith","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/bip.22800","article-title":"Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells","volume":"106","author":"Gilad","year":"2016","journal-title":"Biopolymers"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib84","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ijc.20861","article-title":"Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation","volume":"115","author":"Mathieu","year":"2005","journal-title":"Int J. Cancer"},{"issue":"25","key":"10.1016\/j.phrs.2026.108150_bib85","first-page":"472","article-title":"Human pancreatic cancer cell lines express the CCKB receptor","volume":"46","author":"de Weerth","year":"1999","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2026.108150_bib86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00259-007-0604-1","article-title":"Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin","volume":"35","author":"Laverman","year":"2008","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"issue":"1","key":"10.1016\/j.phrs.2026.108150_bib87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/nat.2016.0621","article-title":"A cholecystokinin B receptor-specific DNA aptamer for targeting pancreatic ductal adenocarcinoma","volume":"27","author":"Clawson","year":"2017","journal-title":"Nucleic Acid. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2026.108150_bib88","doi-asserted-by":"crossref","first-page":"G1244","DOI":"10.1152\/ajpgi.00460.2011","article-title":"Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis","volume":"302","author":"Fino","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108150_bib89","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/cbt.13.3.18698","article-title":"A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer","volume":"13","author":"Smith","year":"2012","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.phrs.2026.108150_bib90","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.18632\/oncotarget.7522","article-title":"Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue","volume":"7","author":"Roy","year":"2016","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.phrs.2026.108150_bib91","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1021\/acs.jmedchem.3c00377","article-title":"Development of highly potent clinical candidates for theranostic applications against cholecystokinin-2 receptor positive cancers","volume":"66","author":"Corlett","year":"2023","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2026.108150_bib92","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41419-022-05463-8","article-title":"Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo","volume":"13","author":"Bachmann","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.phrs.2026.108150_bib93","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1158\/2767-9764.CRC-22-0043","article-title":"Depletion of mannose receptor-positive tumor-associated macrophages via a peptide-targeted star-shaped polyglutamate inhibits breast cancer progression in mice","volume":"2","author":"Lepland","year":"2022","journal-title":"Cancer Res. Commun."},{"issue":"W1","key":"10.1016\/j.phrs.2026.108150_bib94","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:24:31Z","timestamp":1777605871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":94,"alternative-id":["S1043661826000654"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108150","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin\/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108150"}}